Adis Journal Podcasts
67 episodes - English - Latest episode: 26 days ago -Listen to podcasts with key opinion leaders in multiple therapy areas, discussing hot topics including topic overviews, expert opinions and conference overviews.
Brought to you by the Adis Journals Group, part of Springer Nature. The primary audience for these podcasts are healthcare professionals, and are published and citable through the journals.
Homepage Google Podcasts Overcast Castro Pocket Casts RSS feed
Episodes
The Importance of Biomarker Testing in the Treatment of Advanced Non-Small Cell Lung Cancer: A Podcast
April 02, 2024 15:16 - 32 minutes - 41 MBPanel-based sequencing platforms are becoming more accessible, and molecular biomarker analysis of circulating tumor DNA is becoming more common. In this podcast, authors discuss the importance of biomarker testing in advanced non-small cell lung cancer (NSCLC) and explore topics such as testing methodologies, effect of biomarker testing on patient outcomes, emerging technologies, and strategies for improving testing rates in the United States. This podcast is published open access in On...
The Why, What and Where Podcast on the Updated 2023 IWGDF Guideline on Offloading Treatments for Diabetes-Related Foot Ulcers
March 25, 2024 13:13 - 9 minutes - 8.9 MBIn this podcast the Chair and Secretary of the 2023 International Working Group on the Diabetic Foot (IWGDF) guideline on offloading treatments for diabetes-related foot ulcers briefly discuss why we need offloading treatments for people with diabetes-related foot ulcers, what the new international offloading guideline recommends, and where offloading treatment might go into the future. This podcast is published open access in Diabetes Therapy and is fully citeable. You can access the...
Podcast on How to Classify Foot Ulcers in People with Diabetes (2023 Update of the IWGDF Guidelines on Classification)
March 22, 2024 19:02 - 12 minutes - 11.3 MBIn this podcast, the Chair and Secretary of the 2023 update of the International Working Group of the Diabetic Foot (IWGDF) guidelines on Classification discuss the results of update to the guidelines addressing the use of systems to classify foot ulcers in people with diabetes in routine clinical practice. This podcast is published open access in XX and is fully citeable. You can access the original published podcast article through the Diabetes Therapy website and by using this link...
Current and Emerging Treatment Options for Patients with Metastatic EGFR-Mutated Non-small Cell Lung Cancer After Progression on Osimertinib and Platinum-Based Chemotherapy: A Podcast Discussion
March 22, 2024 12:43 - 30 minutes - 19.3 MBPatients with metastatic epidermal growth factor receptor (EGFR)-mutated non-small cell lung cancer (NSCLC) are widely treated with osimertinib, the preferred first-line treatment option. However, disease progression inevitably occurs, driven by EGFR-dependent or EGFR-independent mechanisms of resistance. Platinum-based chemotherapy is the recommended treatment following progression with osimertinib but responses to platinum-based chemotherapy are transient. Salvage therapies, which are used...
Shared Decision-Making on Using a CDK4/6 Inhibitor plus an Aromatase Inhibitor for HR+/HER2− Metastatic Breast Cancer: A Podcast
March 22, 2024 12:42 - 15 minutes - 15.6 MBIn this podcast, authors discuss how to ensure that individual patients’ needs and concerns are addressed when it comes to shared decision-making on treatment for metastatic breast cancer. Including an overview of different approaches for initial consultations, strategies for tailoring conversations based on a patient’s background or health literacy, and trustworthy resources that can help improve patients’ understanding. As an illustrative example, authors focus on how to implement shared d...
The Evolving Role of PD-(L)1 Inhibition in Optimizing Outcomes for High-Risk Non-Muscle-Invasive Bladder Cancer (NMIBC): A Podcast
March 22, 2024 12:34 - 35 minutes - 25.2 MBAuthors Dr Peter Black and Dr Bernie Eigl aim to provide an overview of the non-muscle-invasive bladder cancer (NMIBC) landscape with a focus on high-risk NMIBC. This includes understanding the diagnosis and current treatment approaches with a focus on the medical needs and high-risk NMIBC treatment, highlighting the potential challenges associated with the introduction of programmed cell death ligand 1 (PD-(L)1) therapies in NMIBC. And then provide insights into the patient journey within ...
A Podcast on Pre- or Perioperative Chemoimmunotherapy for Stage III Non-Small Cell Lung Cancer: Shared Agreement from the Thoracic Surgeon and Oncologist Perspectives
March 22, 2024 12:31 - 26 minutes - 32.6 MB VideoIn this podcast, authors Dr Luca Bertolaccini and Dr Giulio Metro touch upon the need for a standard definition of resectability in patients with resectable stage III non-small cell lung cancer (NSCLC). This podcast gives the perspectives of a thoracic surgeon and an oncologist, and suggests a shared agreement between two of the main actors involved in the treatment of resectable stage III NSCLCs. This podcast is published open access in Oncology and Therapy and is fully citeable. You ca...
Optimizing Real-World Outcomes in High-Risk Relapsed/Refractory (r/r) FL with CAR-T Cell Therapy: A Vodcast and Case Example
March 22, 2024 12:27 - 10 minutes - 13.5 MBIn this podcast, author Dr Kai Hübel discussed a case of a patient with high-risk relapse follicular lymphoma. This discussion outlines the potential effectiveness of chimeric antigen receptor (CAR)-T cell therapy in relapsed/refractory follicular lymphoma. This podcast is published open access in Oncology and Therapy and is fully citeable. You can access the original published podcast article through the Oncology and Therapy website and by using this link: https://link.springer.com/arti...
Inotuzumab in Older Patients with Newly Diagnosed Acute Lymphoblastic Leukemia — A Podcast
March 08, 2024 18:04 - 34 minutes - 15.8 MBIn this podcast, Elias Jabbour from the University of Texas MD Anderson Cancer Center, Houston, TX, and Matthias Stelljes Universitätsklinikum Münster, Münster, Germany summarize and highlight some of the recent findings on the use of inotuzumab ozogamicin as induction therapy for older adults with newly diagnosed acute lymphoblastic leukemia (ALL). This peer-reviewed podcast is published open access in Targeted Oncology and is fully citable. You can access the original published podcast ...
A Patient-Centered Approach to Vernal Keratoconjunctivitis (VKC): A Podcast
March 04, 2024 11:27 - 35 minutes - 30.5 MBThis podcast is published open access in Ophthalmology and Therapy and is fully citeable. You can access the original published podcast article through the Ophthalmology and Therapy website and by using this link. All conflicts of interest can be found online. Open Access This podcast is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License, which permits any non-commercial use, sharing, adaptation, distribution and reproduction in any medium or format, as...
Cross-speciality Perspectives on Practical Management of Atopic Dermatitis-Associated Ocular Surface Diseases
February 08, 2024 07:45 - 21 minutes - 12.7 MBThis podcast is published open access in Dermatology and Therapy and is fully citeable. You can access the original published podcast article through the Dermatology and Therapy website and by using this link: https://link.springer.com/article/10.1007/s13555-023-01093-w. All conflicts of interest can be found online. Open Access This podcast is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License, which permits any non-commercial use, sharing, adaptation,...
A Podcast on the Use of CGM in Optimizing Type 2 Diabetes Management with Non-intensive Insulin Treatment in the Primary Care Setting
January 15, 2024 11:45 - 27 minutes - 25.7 MBIn this podcast, we are joined by Professor Sam Seidu who discusses the potential of continuous glucose monitoring (CGM) in managing type 2 diabetes with non-intensive insulin treatment in primary care. This includes a discussion on the evidence for CGM use, the role of primary healthcare in diabetes management, and some practical tips for interpreting the Ambulatory Glucose Profile (AGP) report. This podcast is published open access in Diabetes Therapy and is fully citeable. You can a...
Podcast: Influenza-Associated Complications and the Impact of Vaccination on Public Health
November 24, 2023 16:40 - 22 minutes - 14.7 MBThis podcast is published open access in Infectious Diseases and Therapy and is fully citeable. You can access the original published podcast article through the Infectious Diseases and Therapy website and by using this link: https://link.springer.com/article/10.1007/s40121-023-00885-z. All conflicts of interest can be found online. Open Access This podcast is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License, which permits any non-commercial use,...
Podcast on Identifying and Understanding Barriers to Care in Undeserved Populations With MS in the United States
November 21, 2023 10:17 - 16 minutes - 13 MBThis podcast is published open access in Neurology and Therapy and is fully citeable. You can access the original published podcast article through the Neurology and Therapy website and by using this link: Podcast on Identifying and Understanding Barriers to Care in Underserved Populations With MS in the United States | Neurology and Therapy (springer.com). All conflicts of interest can be found online. Open Access This podcast is licensed under a Creative Commons Attribution-NonCom...
Podcast on Self-administered Intranasal Etripamil for Symptomatic Paroxysmal Supraventricular Tachycardia: The RAPID Trial
November 15, 2023 10:45 - 27 minutes - 20.5 MBIn this podcast, Dr Lip and Dr Stambler discuss the RAPID trial (NCT03464019), which was a phase 3 study that evaluated the safety and efficacy of etripamil in terminating PSVT episodes using a repeat-dosing regimen. RAPID was a multicenter, randomized trial that enrolled adults with electrocardiograph (ECG)-documented PSVT episodes lasting ≥ 20 min. This podcast is published open access in Cardiology and Therapy and is fully citeable. You can access the original published podcast article ...
EGFR Tyrosine Kinase Inhibitors for the Treatment of Metastatic Non-Small Cell Lung Cancer Harboring Uncommon EGFR Mutations: A Podcast
October 04, 2023 10:54 - 41 minutes - 21.3 MBIn this podcast, Xiuning Le from the University of Texas MD Anderson Cancer Center, Houston, TX, Eric Nadler from the Baylor University Medical Center, Dallas, TX, Daniel Costa from the Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, and John Heymach from the University of Texas MD Anderson Cancer Center, Houston, TX discuss the use of EGFR tyrosine kinase inhibitors for the treatment of metastatic non-small cell lung cancer harboring uncommon EGFR mutations. This...
Biomarker Testing for Actionable Alterations in NSCLC—Perspectives from US-Based Academic and Community Oncologists: A Podcast
October 03, 2023 09:07 - 33 minutes - 26.2 MBThis podcast is published open access in Advances in Therapy and is fully citeable. You can access the original published podcast article through the Advances in Therapy website and by using this link: https://link.springer.com/article/10.1007/s12325-023-02664-1. All conflicts of interest can be found online. Open Access This podcast is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License, which permits any non-commercial use, sharing, adaptation, di...
Biomarker Testing for Actionable Alterations in NSCLC—Perspectives from US-Based Academic and Community Oncologists: A Podcast
October 02, 2023 16:52 - 33 minutes - 26.2 MBThis podcast is published open access in Advances in Therapy and is fully citeable. You can access the original published podcast article through the Advances in Therapy website and by using this link: Biomarker Testing for Actionable Alterations in NSCLC—Perspectives from US-Based Academic and Community Oncologists: A Podcast | Advances in Therapy (springer.com). All conflicts of interest can be found online. Open Access This podcast is licensed under a Creative Commons Attribution...
Expert Discussion on Challenges in C3G Diagnosis: A Podcast Article on Best Practices in Kidney Biopsies
September 27, 2023 11:46 - 26 minutes - 21.6 MBThis podcast is published open access in Advances in Therapy and is fully citeable. You can access the original published podcast article through the Advances in Therapy website and by using this link: Expert Discussion on Challenges in C3G Diagnosis: A Podcast Article on Best Practices in Kidney Biopsies | Advances in Therapy (springer.com). All conflicts of interest can be found online. Open Access This podcast is licensed under a Creative Commons Attribution-NonCommercial 4.0 In...
EGFR Mutations Are Not All the Same: the Importance of Biomarker Testing in Non-small Cell Lung Cancer (NSCLC)—A Podcast Discussion Between Patients and Oncologists
September 27, 2023 10:30 - 47 minutes - 34.5 MBIn this podcast, two oncologists and two patient advocates from the patient advocacy group EGFR Resisters talk about the importance of biomarker testing for patients with non-small cell lung cancer and how this can affect treatment decisions and personalised medicine. The panel discusses what biomarkers are, the processes involved in obtaining biomarker testing, how biomarker information is used, and the importance of waiting for biomarker results prior to determining treatment. The panel a...
Uterine Fibroids: A Podcast on Patient and Physician Perspectives on Medical Management and a New Medical Therapy (Relugolix Combination Therapy)
September 20, 2023 13:02 - 23 minutes - 27.1 MBThis podcast is published open access in Advances in Therapy and is fully citeable. You can access the original published podcast article through the Advances in Therapy website and by using this link: Uterine Fibroids: A Podcast on Patient and Physician Perspectives on Medical Management and a New Medical Therapy (Relugolix Combination Therapy) | Advances in Therapy (springer.com). All conflicts of interest can be found online. Open Access This podcast is licensed under a Cre...
Genetic Testing in Metastatic Breast Cancer in the USA: A Podcast
September 15, 2023 11:15 - 28 minutes - 24.2 MBIn this podcast, a healthcare professional discusses germline genetic testing with a patient advocate and answers questions regarding the importance of testing in patients with metastatic breast cancer, with a specific focus on germline or inherited breast cancer susceptibility gene (BRCA) mutations. In the USA, national guidelines recommend that all patients with recurrent or metastatic breast cancer should be offered genetic testing for germline breast cancer susceptibility gene 1 or 2 (BR...
Podcast on Lorlatinib as a First-Line Treatment Option for Patients with ALK-Positive Metastatic NSCLC with Brain Metastasis
August 14, 2023 08:58 - 37 minutes - 27.2 MBBrain metastases are especially common in anaplastic lymphoma kinase (ALK)-positive non-small cell lung cancer (NSCLC), with a cumulative incidence of over 50% and associated with a poor prognosis, high symptom burden, and decreased quality of life. In this podcast, authors discuss the clinical significance of controlling the onset of brain metastases, considerations in selecting a first-line therapy option, efficacy and safety observed in patients with and without brain metastases, and rati...
First Line Medical Treatment of Metastatic Renal Cell Carcinoma: A Podcast on Choosing Wisely and Managing Safely
July 13, 2023 08:25 - 16 minutes - 11.9 MBWith recent advancements in medical treatments for metastatic renal cell carcinoma (mRCC), increased treatment efficiency may also come with increased toxicity. In this podcast, authors discuss the appropriate management of the adverse events that result from drug toxicity in order to achieve optimal oncological outcomes for their patients whilst still maintaining their quality of life. This podcast is published open access in Advances in Therapy and is fully citeable. You can access the o...
A Podcast Discussion on the Current Treatment Landscape for Renal Cell Carcinoma
July 12, 2023 08:55 - 26 minutes - 25.2 MBThis podcast covers the recent developments in the treatment of metastatic renal cell carcinoma (mRCC) and the ongoing phase 3 trials in this space. Whilst reflecting on these data, as well as the current ESMO guidelines, authors discuss how to choose the appropriate treatment for individualized treatment journeys for patients and talk through the strengths and weaknesses of first-line therapy options. This podcast is published open access in Advances in Therapy and is fully citeable. You ...
How I Treat Chronic Inflammatory Demyelinating Polyneuropathy Podcast
June 27, 2023 10:19 - 27 minutes - 19.4 MBThis podcast is published open access in Neurology and Therapy and is fully citeable. You can access the original published podcast article through the Neurology and Therapy website and by using this link: How I Treat Chronic Inflammatory Demyelinating Polyneuropathy Podcast | SpringerLink All conflicts of interest can be found online. Open Access This podcast is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License, which permits any non-commercial us...
Podcast on the Challenges and Recommendations to Address Unmet Needs in MS for LGBTQ+ Populations in the United States
June 27, 2023 09:26 - 19 minutes - 13.6 MBThis podcast is published open access in NETH and is fully citeable. You can access the original published podcast article through the NETH website and by using this link: https://link.springer.com/article/10.1007/s40120-023-00506-4 All conflicts of interest can be found online. Open Access This podcast is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License, which permits any non-commercial use, sharing, adaptation, distribution and reproduction in an...
Bispecific Monoclonal Antibodies in Multiple Myeloma: Data from ASH 2022: A Podcast
June 20, 2023 08:24 - 49 minutes - 38.4 MBIn this podcast, the authors summarize and highlight some of the T cell–redirecting bispecific antibodies (BsAb) currently in development for the treatment of relapsed/refractory multiple myeloma with a focus on the data reported at the oral session for BsAb at the American Society of Hematology’s 2022 meeting from clinical phase 1 and 2 studies. The six presentations reported the latest safety and efficacy data for the BsAb: talquetamab, elranatamab, teclistamab, forimtamig, and alnuctamab...
Expert Perspectives on the Vaccination of Individuals Who Are at Increased Risk of Meningococcal Disease Due to Medical Conditions: A Podcast
June 13, 2023 08:28 - 22 minutes - 13.1 MBIn this podcast, experts discuss the challenges for implementing vaccine recommendations for individuals with medical conditions at increased risk of developing meningococcal disease. Strategies to increase vaccine coverage are also discussed. This podcast is published open access in Infectious Diseases and Therapy and is fully citeable. You can access the original published podcast article through the Infectious Diseases and Therapy website and by using this link: https://link.sprin...
Patient and Healthcare Professional Perspectives from ESMO 2022 on Bladder and Kidney Cancer: A Podcast
June 07, 2023 10:30 - 31 minutes - 17.2 MBIn this plain language podcast, highlights from the European Society for Medical Oncology (ESMO) Congress are discussed for a second year in a row, from the perspective of both a patient advocate and a healthcare professional. Here, the authors discuss the importance of involving patients in the design of clinical trials, as well as strategies to improve dialogue and connections between clinicians, researchers and patients. This podcast is published open access in Oncology and Therapy and...
Podcast to Discuss Therapy Management for Patients with Metastatic Renal Cell Carcinoma Receiving First-Line Axitinib Plus an Immune Checkpoint Inhibitor
May 31, 2023 10:46 - 31 minutes - 21.7 MBThis podcast covers topics including the metastatic renal cell carcinoma landscape with a focus on immune-oncology (IO) agents and tyrosine kinase inhibitors, axitinib indication (combination and monotherapy), a summary of efficacy and safety data, dose modification guidelines, and author experience of managing patients with the most common adverse events (AEs) encompassing prior to initiating therapy, patient education, and follow-up. This podcast is published open access in Advances ...
P-REALITY X: A Real-World Analysis of Palbociclib Plus an Aromatase Inhibitor in HR+/HER2− Metastatic Breast Cancer—A Podcast
May 06, 2023 19:38 - 16 minutes - 9.59 MBIn this podcast, Adam Brufsky from the UPMC Hillman Cancer Center, Magee-Women’s Hospital, University of Pittsburgh Medical Center in Pittsburgh, and Christopher Gallagher from the Washington Cancer Institute, MedStar Washington Hospital Center, Washington, DC discuss how real-world data in heterogeneous patient populations can complement clinical trial data in informing treatment decision making for patients with hormone receptor-positive/human epidermal growth factor receptor 2-negative (H...
HER2-Low Breast Cancer—Diagnostic Challenges and Opportunities for Insights from Ongoing Studies: A Podcast
May 03, 2023 17:33 - 28 minutes - 11.7 MBIn this podcast, Aditya Bardia from the Massachusetts General Hospital, Harvard Medical School in Boston, and Giuseppe Viale from the Department of Pathology and Laboratory Medicine at the European Institute of Oncology in Milan discuss HER2-low breast cancer, including the implications of the recent US FDA and EU approval of trastuzumab deruxtecan (T-DXd) for use in patients with HER2-low breast cancer, the new challenges that this development presents, and ongoing research that will help r...
Podcast on the Art of the Patient Conversation: Healthcare Provider Perspectives to Improve Outcomes in Multiple Sclerosis
March 14, 2023 11:39 - 22 minutes - 16.4 MBIn this podcast article, nurse practitioners discuss multimodal strategies that enable appropriate conversations to meet patients’ needs through the following four techniques: patient-centric language, teach-back, open-ended questions, and active listening and paraphrasing. These techniques are incorporated into example patient–provider conversations to demonstrate their effectiveness in clinical practice. Comprehensive patient conversations and optimizing patient interactions builds a trust...
Living with Type 2 Diabetes: Podcast of a Patient–Physician Discussion
March 06, 2023 14:38 - 18 minutes - 11.3 MBIn this podcast, authors Pamela Kushner and Anne Dalin provide a patient and a clinician discussion on a lived experience of the diagnosis of type 2 diabetes, and the importance of patient education for understanding and managing type 2 diabetes and its complications. This podcast is published open access in Diabetes Therapy and is fully citeable. You can access the original published podcast article through the Diabetes Therapy website and by using this link: https://link.springer.com...
Current and Future Perspectives of Health-Related Quality of Life in Resectable EGFR-Mutated Non-Small Cell Lung Cancer (NSCLC): A Podcast
December 22, 2022 09:49 - 39 minutes - 23 MBIn this podcast, Thomas John from the Department of Medical Oncology at the Peter MacCallum Cancer Centre in Melbourne, Margarita Majem from the Department of Medical Oncology at the Hospital de la Santa Creu i Sant Pau in Barcelona, Diane Legg, founder of LUNGSTRONG, and Jonathan Goldman from the David Geffen School of Medicine at the University of California in Los Angeles discuss health-related quality of life in resectable EGFR-mutant non-small cell lung cancer. This podcast is publish...
Diabetes Therapy Podcast: Real-World Data for Glucose Sensing Technologies in Type 1 Diabetes
December 13, 2022 16:04 - 27 minutes - 24 MBThis podcast with Nick Oliver from Department of Metabolism, Digestion and Reproduction, Faculty of Medicine, Imperial College London discusses real-world data from glucose sensing technologies in type 1 diabetes. This podcast is published open access in Diabetes Therapy and is fully citeable. You can access the original published podcast article through the Diabetes Therapy website and by using this link: https://link.springer.com/article/10.1007/s13300-022-01331-y. All conflicts of ...
Diabetes Therapy Podcast: Mind–Body Medicine in Diabetes Management
September 01, 2022 08:39 - 31 minutes - 29.1 MBThis podcast with Sanjay Kalra from Department of Endocrinology at Bharti Hospital and Vaishali Deshmukh from Deenanath Mangeshkar Hospital discuss Mind–Body Medicine in Diabetes Management. This podcast is published open access in Diabetes Therapy and is fully citeable. You can access the original published podcast article through the Diabetes Therapy website and by using this link: https://link.springer.com/article/10.1007/s13300-022-01305-0. All conflicts of interest can be found on...
A Patient Perspective on Quality of Life with wAMD: A Podcast
June 13, 2022 08:29 - 27 minutes - 16 MBThis podcast is published open access in Ophthalmology and Therapy and is fully citeable. You can access the original published podcast article through the Ophthalmology and Therapy website and by using this link: https://link.springer.com/article/10.1007/s40123-022-00528-5. All conflicts of interest can be found online. Open Access This podcast is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License, which permits any non-commercial use, sharing, adapt...
The FIDELIO Study Podcast
April 05, 2022 14:31 - 24 minutes - 19.9 MBIn this podcast, Robert Toto, Professor of Internal Medicine at the University of Texas Southwestern Medical Center and George Bakris, Professor of Medicine and Director of the American Heart Association Comprehensive Hypertension Center at the University of Chicago discuss the key findings from the FIDELIO study. This podcast is published open access in Diabetes Therapy and is fully citeable. You can access the original published podcast article through the Diabetes Therapy website an...
Aldosterone and Mineralocorticoid Receptor Antagonists in 2021: A Paradigm Shift
March 18, 2022 09:25 - 24 minutes - 17.2 MBIn this podcast, Dr Murray Epstein, Professor of Medicine Emeritus in the division of Nephrology and Hypertension at the University of Miami, Miller School of Medicine, discusses Aldosterone and Mineralocorticoid Receptor Antagonists in 2021. This podcast is published open access in Diabetes Therapy and is fully citeable. You can access the original published podcast article through the Diabetes Therapy website and by using this link: https://link.springer.com/article/10.1007/s13300-022-01...
Patient and Healthcare Professional Perspectives from ESMO 2021 on Bladder and Kidney Cancer: A Podcast
March 04, 2022 09:21 - 27 minutes - 22 MBIn this plain language podcast, highlights from the European Society for Medical Oncology (ESMO) Congress 2021 are discussed from the perspective of both a patient and a healthcare professional by authors Alex Filicevas & Thomas B. Powles. Data from studies in bladder and kidney cancer offer new hope for patients; however, expectations in the patient community must be managed, accounting for the time it takes for research data to influence clinical practice. This podcast is publish...
Podcast on the Management of Adverse Events Associated with Lorlatinib
February 11, 2022 16:21 - 32 minutes - 20.2 MBHere Dr Todd Bauer and Dr Erin Bertino cover some of the unmet needs in patients with anaplastic lymphoma kinase-positive lung cancer, the development of lorlatinib, and how it's being used in clinical practice. They also look at how to manage some of the common adverse events, particularly central nervous system toxicity and hyperlipidemia, that they see a lot in the clinic. This podcast is published open access in Advances in Therapy and is fully citeable. You can access the original pub...
Chronic Myeloid Leukemia Data at ASH 2021: A Podcast on Patient Unmet Needs and Later-Line Treatment Developments
January 31, 2022 15:05 - 14 minutes - 13 MBDr. Massimo Breccia from the Department of Translational and Precision Medicine at the University of Rome joins us to talk through the top highlights of the chronic myeloid leukemia data from the 2021 American Society of Hematology Conference. Here he gives specific focus to patient unmet needs and later-line therapies for the disease. This podcast is published open access in Advances in Therapy and is fully citeable. You can access the original published podcast article through the Advanc...
Podcast on B Cell-Targeting Therapies and Other Multiple Sclerosis Concerns During COVID-19
January 24, 2022 11:02 - 28 minutes - 20.4 MBDr Robert K. Shin, Dr Pavle Repovic and Dr Joseph R. Berger discuss the topic of B cell-targeting therapies and other concerns for those living with multiple sclerosis during the COVID-19 pandemic. This podcast is published open access in Neurology and Therapy and is fully citeable. You can access the original published podcast article through the Neurology and Therapy website and by using this link: https://link.springer.com/article/10.1007/s40120-021-00321-9. All conflicts of intere...
American Society of Clinical Oncology 2021 Podcast: HR+, HER2− Breast Cancer
August 10, 2021 09:48 - 22 minutes - 16.5 MBKwok-Leung Cheung of the University of Nottingham discusses his highlights from the American Society of Clinical Oncology 2021 conference, specifically focusing on the data released on hormone receptor-positive, human epidermal receptor 2-negative breast cancer. This podcast is published open access in Oncology and Therapy journal and is fully citeable. You can access the published commentary to go alongside this podcast through the Oncology and Therapy website and by using this link: http...
Expert Perspectives on COVID-19 Vaccination for People Living with Multiple Sclerosis
August 05, 2021 17:15 - 25 minutes - 22.9 MBDr Robert K. Shin, Dr Kottil W. Rammohan and Dr Mitzi J. Williams discuss the topic of COVID-19 vaccination for people living with Multiple Sclerosis. This podcast is published open access in the journal Neurology and Therapy and is fully citeable. You can access the published commentary to go alongside this podcast through the Neurology and Therapy website and by using this link: https://link.springer.com/article/10.1007/s40120-021-00266-z. All conflicts of interest can be found online i...
The Stability of the Red Reflex Produced by Different Surgical Ophthalmic Microscopes
July 13, 2021 16:00 - 6 minutes - 10.3 MBThis podcast is published open access in Ophthalmology and Therapy journal and is fully citeable. You can access the published commentary to go alongside this podcast through the Ophthalmology and Therapy website and by using this link: https://link.springer.com/article/10.1007/s40123-021-00367-w. All conflicts of interest can be found online. This podcast is intended for medical professionals only. Open Access This podcast is licensed under a Creative Commons Attribution-NonCommercia...
Diabetes Therapy Podcast Collection: Language Matters in Diabetes
June 01, 2021 16:30 - 30 minutes - 15.9 MBThis podcast, brought to you by Editorial Board member Sanjay Kalra, and diabetes expert Partha Kar, discusses the importance of language in diabetes, highlighting the importance of talking to your patients and how that can assist you and them. This podcast is published open access in Diabetes Therapy journal and is fully citeable. You can access the published commentary to go alongside this podcast through the Diabetes Therapy website and by using this link: https://link.springer.com/art...
Pulmonary Therapy Podcast—COVID-19: Research and Real-World Experiences from the Editorial Board
May 11, 2021 16:25 - 26 minutes - 37.9 MBThis podcast comes from the Ed Board members of Pulmonary Therapy, Kai Michael Beeh, Nazia Chaudhuri, Timothy J. Craig, Alan Kaplan & Marcus Peter Kennedy, discussing their experiences from the COVID-19 crisis over the past year. This podcast is published open access in Pulmonary Therapy journal and is fully citeable. You can access the published commentary to go alongside this podcast through the Pulmonary Therapy website and by using this link: https://link.springer.com/article/10.1007/...